Web25 apr 2024 · In March 2024, Canadian pharmaceutical corporations Arbutus Biopharma and Genevant Sciences sued Moderna in the US District Court for the District of Delaware for the alleged infringement of US patents linked to the creation of Moderna’s COVID-19 vaccine, mRNA-1273. [1] Arbutus’s president and CEO, William Collier, noted that … Web10 mar 2024 · U.S. District Judge Mitchell Goldberg ruled for the second time that Moderna had not yet shown that the government was the proper target of a lawsuit by Arbutus …
Arbutus and Genevant file patent lawsuit against Moderna for …
Web24 lug 2024 · Arbutus Biopharma () has for some years owned the rights to a technology that can be used to deliver messenger RNA to a patient's cells. Back in January 2024, … Web15 feb 2024 · The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday. The Justice Department's court filing said the United States should be liable for any infringement of Arbutus Biopharma Corp and Genevant Sciences GmbH's patents … fica phase out 2023
Moderna loses bid to shift liability in COVID-19 vaccine patent case
Web28 feb 2024 · Arbutus and Genevant, a joint venture between Arbutus and Roivant Sciences Ltd, told the court that the lawsuit was necessary because Moderna had "consistently declined to engage meaningfully in licensing discussion." Shares of Arbutus were down about 2.5% while Moderna was up 0.6% in late afternoon trading. "Moderna … Web15 mar 2024 · In the first major patent infringement lawsuit in the mRNA space, on February 28, 2024, Arbutus Biopharma Corporation (“Arbutus”) and Genevant Sciences GmbH (“Genevant”) sued Moderna, Inc ... Web28 feb 2024 · WARMINSTER, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company … fica rate for employers 2023